Evidence map›Paper›PMID 33011775›Full record

ArticleEuropean heart journal2020

Development and validation of two SCORE-based cardiovascular risk prediction models for Eastern Europe: a multicohort study.

Taavi Tillmann, Kristi Läll, Oliver Dukes, Giovanni Veronesi, Hynek Pikhart, Anne Peasey, Ruzena Kubinova, Magdalena Kozela, Andrzej Pajak, Yuri Nikitin and 6 more

Erratum issuedAbstract read
In one paragraph

Article in European heart journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. External validation and update of the J-ACCESS model in an Italian cohort of patients undergoing stress myocardial perfusion imaging.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Taavi TillmannDepartment of Epidemiology & Public Health, University College London, 1-19 Torrington Place, London WC1E 7HB, UK.
Kristi LällEstonian Genome Center, Institute of Genomics, University of Tartu, Riia 23b, 51010 Tartu, Estonia.
Oliver DukesDepartment of Applied Mathematics Computer Science and Statistics, Ghent University, Krijgslaan 281, S9, 9000 Ghent, Belgium.
Giovanni VeronesiResearch Center in Epidemiology and Preventive Medicine, University of Insubria, Via O. Rossi 9, 21100 Varese, Italy.
Hynek PikhartDepartment of Epidemiology & Public Health, University College London, 1-19 Torrington Place, London WC1E 7HB, UK.
Anne PeaseyDepartment of Epidemiology & Public Health, University College London, 1-19 Torrington Place, London WC1E 7HB, UK.
Ruzena KubinovaCentre for Environmental Health Monitoring, National Institute of Public Health, Šrobárova 48, 10042 Prague, Czech Republic.
Magdalena KozelaDepartment of Epidemiology and Population Studies, Institute of Public Health, Jagiellonian University Medical College, ul. Grzegórzecka 20, 31531 Krakow, Poland.
Andrzej PajakDepartment of Epidemiology and Population Studies, Institute of Public Health, Jagiellonian University Medical College, ul. Grzegórzecka 20, 31531 Krakow, Poland.
Yuri NikitinResearch Institute of Internal and Preventive Medicine, Branch of the Institute of Cytology and Genetics, SB RAS, 10 Ac. Lavrentieva ave, 630090 Novosibirsk, Russia.
Sofia MalyutinaResearch Institute of Internal and Preventive Medicine, Branch of the Institute of Cytology and Genetics, SB RAS, 10 Ac. Lavrentieva ave, 630090 Novosibirsk, Russia.
Andres MetspaluEstonian Genome Center, Institute of Genomics, University of Tartu, Riia 23b, 51010 Tartu, Estonia.
Tõnu EskoEstonian Genome Center, Institute of Genomics, University of Tartu, Riia 23b, 51010 Tartu, Estonia.
Krista FischerEstonian Genome Center, Institute of Genomics, University of Tartu, Riia 23b, 51010 Tartu, Estonia.
Mika KivimäkiDepartment of Epidemiology & Public Health, University College London, 1-19 Torrington Place, London WC1E 7HB, UK.
Martin BobakDepartment of Epidemiology & Public Health, University College London, 1-19 Torrington Place, London WC1E 7HB, UK.

Funding

Education, socioeconomic status and Aging: transitions from multimorbidity to functional limitations and mortalityR01AG056477 · NIA · UNIVERSITY COLLEGE LONDON · PI KIVIMAKI, MIKA J, SINGH-MANOUX, ARCHANA · 2018 to 2022
$2.8M
Health disparities and agingin societies in transitionR01AG023522 · NIA · UNIVERSITY COLLEGE LONDON · PI MARMOT, MICHAEL G · 2004 to 2008
$2.2M
Medical Research Council MR/R024227/1NIA NIH HHS R01 AG023522NIA NIH HHS R01 AG056477Wellcome TrustWellcome Trust 064947/Z/01/ZWellcome Trust 106554/Z/14/Z
6 · The paper itself

Abstract

aimsCardiovascular disease (CVD) risk prediction models are used in Western European countries, but less so in Eastern European countries where rates of CVD can be two to four times higher. We recalibrated the SCORE prediction model for three Eastern European countries and evaluated the impact of adding seven behavioural and psychosocial risk factors to the model. METHODS AND

resultsWe developed and validated models using data from the prospective HAPIEE cohort study with 14 598 participants from Russia, Poland, and the Czech Republic (derivation cohort, median follow-up 7.2 years, 338 fatal CVD cases) and Estonian Biobank data with 4632 participants (validation cohort, median follow-up 8.3 years, 91 fatal CVD cases). The first model (recalibrated SCORE) used the same risk factors as in the SCORE model. The second model (HAPIEE SCORE) added education, employment, marital status, depression, body mass index, physical inactivity, and antihypertensive use. Discrimination of the original SCORE model (C-statistic 0.78 in the derivation and 0.83 in the validation cohorts) was improved in recalibrated SCORE (0.82 and 0.85) and HAPIEE SCORE (0.84 and 0.87) models. After dichotomizing risk at the clinically meaningful threshold of 5%, and when comparing the final HAPIEE SCORE model against the original SCORE model, the net reclassification improvement was 0.07 [95% confidence interval (CI) 0.02-0.11] in the derivation cohort and 0.14 (95% CI 0.04-0.25) in the validation cohort.

conclusionOur recalibrated SCORE may be more appropriate than the conventional SCORE for some Eastern European populations. The addition of seven quick, non-invasive, and cheap predictors further improved prediction accuracy.

Indexed as

Cardiovascular DiseasesCohort StudiesCzech RepublicHeart Disease Risk FactorsHumansPolandProspective StudiesRisk AssessmentRisk FactorsRussiaCardiovascular diseasesEastern EuropePsychosocial deprivationRisk predictionSensitivity and specificitySocioeconomic factors

Identifiers

PMID33011775
PMCPMC7544536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.